title: Interferon-induced hypothyroidism causing reversible pituitary enlargement.
abstract: OBJECTIVE
  To present the first reported case of interferon-induced hypothyroidism with radiographic confirmation of secondary pituitary hyperplasia.
  
  
  METHODS
  We describe the case of a woman with recurrent malignant melanoma, outline the details of her endocrine work-up, and illustrate the serial findings on magnetic resonance imaging of the head.
  
  
  RESULTS
  A 26-year-old woman underwent surgical excision of a melanoma of the left thigh and 10 years later had a second melanoma removed from her right knee. Metastatic work-up revealed evidence of tumor involvement in the cervical and mediastinal lymph nodes. After treatment with interferon for 1 year, persistent fatigue and menstrual irregularities led to the laboratory diagnosis of hypothyroidism, and magnetic resonance imaging revealed pituitary enlargement. Both her endocrinopathy and the pituitary hyperplasia resolved with discontinuation of the interferon treatment and with institution of thyroid replacement therapy.
  
  
  CONCLUSIONS
  Clinicians should be aware of the potential adverse effects of interferon therapy to avoid inappropriate diagnosis of a pituitary adenoma or metastatic lesion in patients with cancer who are treated with interferon. In addition, screening for hypothyroidism should be performed in patients receiving interferon.
authors.affiliation: The Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.
authors.forename: Giacomo G
authors.initials: GG
authors.lastname: Vecil
authors.forename: Nicholas V
authors.initials: NV
authors.lastname: Papadopoulos
authors.forename: Rena
authors.initials: R
authors.lastname: Vassilopoulou-Sellin
authors.forename: Ian E
authors.initials: IE
authors.lastname: McCutcheon
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D006965:Hyperplasia; D007037:Hypothyroidism / Q000139:chemically induced* / Q000473:pathology; D007372:Interferons / Q000009:adverse effects* / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D010902:Pituitary Gland / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000473:pathology; D011859:Radiography
chemical_list: D007372:Interferons